Decentraland has reached new highs as the metaverse hype continues. Some interesting developments in the metaverse of the project have also been responsible for the spike upwards. The cryptocurrency has been surging upwards as November began and after a few minor corrections, the upward trajectory resumed during the month. A new all-time high was established […]
Decentraland – Most expensive real estate purchase Read More »
Applied UV, Inc. (AUVI) saw a decline of 6.86% in the aftermarket. However, the last trading session closed at $5.1 with an incline of 2%. Monthly Preferred Stock Dividend On 23rd November 2021, AUVI announced that the holders of the 10.5% Series A Cumulative Perpetual Preferred Stock will get a cash dividend equal to $0.21875
Applied UV, Inc. (AUVI) stock is down in aftermarket – What’s up? Read More »
Paratek Pharmaceuticals, Inc. (PRTK), a commercial-stage biopharmaceutical company, has surged 7.30% in aftermarket trading session. Consequently, PRTK stock is trading at $4.70 at the time of the writing. The speculations regarding the approval of NUZYRA (omadacycline), a novel antibiotic being produced by the company, in China have catalyzed the movement of stock. On Friday, PRTK
Datasea Inc. (DTSS), a company that provides smart security solutions in the People’s Republic of China, has declined 5.26% in aftermarket trading session. As a result, DTSS stock is trading at $1.62 at the time of the writing. The decline could be attributed to short selling by certain investors. On Friday, DTSS closed the day at $1.71
Datasea Inc. (DTSS) Stock Declining in Aftermarket, Here’s the Reason Read More »
Dermata Therapeutics Inc. (DRMA), a clinical-stage biotechnology company, has surged 8.52% on aftermarket trading session. As a result, DRMA stock is trading at $2.93 at the time of the writing. Analysts have attributed this rise to insider buying as the major owner of the company, Proehl Gerald, picked up 20,000 shares at a common stock price
Dermata Therapeutics Inc. (DRMA) Stock Surging in Aftermarket, Here’s the Reason Read More »
U.S. Xpress Enterprises, Inc. (USX) experienced a decline of 5.58% in the aftermarket. However, the last trading session closed at $8.25 with a decline of 4.62%. Stephens Annual Investment Conference – Latest Updates USX announced on 18th November 2021 that Eric Fuller and Eric Peterson will participate in Stephens Annual Investment Conference at 2:00 p.m.
U.S. Xpress Enterprises, Inc. (USX) stock is falling to 5.58% – Recent news to know! Read More »
VolitionRx Limited (VNRX) experiences a decline of 8.05% in the aftermarket. However, the last trading session closed at $3.48 with a decrease of 5.95%. Third Quarter 2021 Results by VNRX– What’s up? VNRX announced third-quarter financial results on 10th November 2021. The report says that the cash and cash equivalents came out to be $22.9
VolitionRx Limited (VNRX) stock is going down to 8.05% – What’s happening? Read More »
Unity Biotechnology Inc. (UBX) stock went up by 8.60% at $2.40 in the aftermarket, against $2.21 at its previous close on November 26. In the last market session, the stock lost 4.74% or $0.11 at a volume of 624.37 thousand. The day range for the stock was $2.20 to $2.36, while it saw a high
Here’s why Unity Biotechnology Inc. (UBX) gained in the After hours Read More »
Avalon GloboCare Corp. (AVCO) has seen a jump of 6.28% in the aftermarket. However, the last trading session closed at $0.9221 with a decline of 5.23%. US and International Patent Application – Worth it? On 14th October 2021, AVCO reported that it has effectively co-developed a unique platform of S-layer coated emulsome technology (SLET). Emulsomes
Benitec Biopharma Inc. (NASDAQ: BNTC) stock declined by 1.54% at last close while the BNTC stock price plunged by 9.69% in the after-hours trading session. Benitec Biopharma, based in Hayward, California, is a development-stage biotechnology business focused on the advancement of innovative genetic therapies. BNTC stock’ Financial Highlights On Nov 15, 2021, Benitec Biopharma announced
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.